Vidwan-ID : 81801



  • Dr Kumaraswamy H M

  • Assistant Professor
  • Kuvempu University
Publications 2007 - 2017

Publications

  • 13
    Journal Articles
  • 5
    Conference Article
  • 5
    Projects
  • 3

Citations / H-Index

294 Citations
3 h-index
211 Citations

Altmetrics

1
67

Google Scholar

Co-author Network


Expertise

Biotechnology and Applied Microbiology

Cancer Biology, Signalling, Medicinal Plants, Anti-cancer Therapeutics

Personal Information

Dr Kumaraswamy H M

Male
Associate Professor Dept of Biotechnology, Kuvempu Unversity, Bioscience complex
Shimoga, Karnataka, India - 577451


Experience

  • Assistant Professor

    Department of Biotechnology

    Kuvempu University


Qualification

  • MSc, Ph D

    Kuvempu University


Honours and Awards

2013

Sir CV Raman Post-Doctoral Award tenable in USA

University Grants Commission, Govt. of India.

2013

Sir CV Raman Post-Doctoral Award tenable in USA

University Grants Commission, Govt. of India.

Read Less

Doctoral Theses Guided

2022

Investigation and screening of bioactive constituents from Artabotrys odoratissimus R. Br.

Dr. Meghana P, Kuvempu University

2022

Investigation and screening of bioactive constituents from Artabotrys odoratissimus R. Br.

Dr. Meghana P, Kuvempu University

Read Less

Membership In Professional Bodies

2022

Association for Food Science Technologists of India

Life Member

2020

Indian Association for Cancer Research

Life Member

2014

Society of Biological Chemists

Life Member

2022

Association for Food Science Technologists of India

Life Member

2020

Indian Association for Cancer Research

Life Member

2014

Society of Biological Chemists

Life Member

Read Less

Research Projects

Repositioning HIF 1 alfa inhibitor BP-1B for DNA damage response (DDR) to induce bracaness in cancer

Funding Agency : ICMR, Govt. of India

Embelin can modulate Ataxia Telegiectasis Mutated (ATM) signalling in nicotine induced chemoresistant pancreatic cancer

Funding Agency : DST, Govt. Of India

Acetogenins modulate ATM signalling pathway in nicotine induced chemoresistance in Pancreatic cancer

Funding Agency : DST-WOSA, Govt. Of India

Read More

Repositioning HIF 1 alfa inhibitor BP-1B for DNA damage response (DDR) to induce bracaness in cancer

Funding Agency : ICMR, Govt. of India

Embelin can modulate Ataxia Telegiectasis Mutated (ATM) signalling in nicotine induced chemoresistant pancreatic cancer

Funding Agency : DST, Govt. Of India

Acetogenins modulate ATM signalling pathway in nicotine induced chemoresistance in Pancreatic cancer

Funding Agency : DST-WOSA, Govt. Of India

Design and Development of tumor targeted embelin loaded nano particles

Funding Agency : VGST-Govt. of Karnataka

Evaluation of Anti arthritic property of the bioactive constituents from Embelia ribes

Funding Agency : University Grants Commission

Read Less